Biocorrx Inc (BICX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.2866 -0.2034 (-41.51%) 04/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.2866 unch (unch) 12:21 ET
for Mon, Apr 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -5,212 | -3,771 | -4,377 | -5,211 | -3,507 |
Depreciation Amortization | 1,197 | 844 | 637 | 646 | 647 |
Accounts receivable | 1 | 35 | -34 | -1 | 0 |
Other Working Capital | 1,523 | 714 | 578 | 704 | 378 |
Other Operating Activity | 1,395 | 325 | 1,155 | 324 | 329 |
Operating Cash Flow | $-1,096 | $-1,853 | $-2,042 | $-3,538 | $-2,152 |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | N/A | N/A | -2 | -9 |
Purchase Sale Intangibles | N/A | N/A | N/A | -48 | N/A |
Other Investing Activity | 0 | 0 | 0 | -48 | 0 |
Investing Cash Flow | $N/A | $N/A | $N/A | $-50 | $-9 |
Cash Flows From Financing Activities | |||||
Debt Issued | 1,132 | 971 | 775 | 831 | 102 |
Debt Repayment | -11 | -35 | N/A | N/A | N/A |
Common Stock Issued | N/A | 915 | 1,250 | 2,250 | N/A |
Other Financing Activity | -1 | -1 | 0 | 0 | 5 |
Financing Cash Flow | $1,119 | $1,850 | $2,025 | $3,081 | $107 |
Beginning Cash Position | 65 | 69 | 86 | 592 | 2,646 |
End Cash Position | 88 | 65 | 69 | 86 | 592 |
Net Cash Flow | $23 | $-3 | $-17 | $-506 | $-2,054 |
Free Cash Flow | |||||
Operating Cash Flow | -1,096 | -1,853 | -2,042 | -3,538 | -2,152 |
Capital Expenditure | N/A | N/A | N/A | -2 | -9 |
Free Cash Flow | -1,096 | -1,853 | -2,042 | -3,540 | -2,161 |